Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 43 publications
Buprenorphine for Chronic Pain Management in Sickle Cell Disease: A Scoping Review of Current Evidence.
Journal: The primary care companion for CNS disorders
Published: June 18, 2026
Emerging Concern: Lidocaine Adulterated "Purple Fentanyl" in the Midwest.
Journal: Kansas journal of medicine
Published: October 10, 2025
Nitrous Oxide and Ketamine Use Producing Ataxia and Neuropathy: A Clinical Case Report.
Journal: The primary care companion for CNS disorders
Published: July 12, 2025
Concomitant Tianeptine and Alcohol Use Disorders: Diagnosis and Treatment with Buprenorphine-Naloxone.
Journal: Kansas journal of medicine
Published: March 11, 2025
Tianeptine as an opiate replacement in a patient on methadone treatment: A case report.
Journal: Journal of opioid management
Published: March 27, 2024
Buprenorphine: two adolescent case reports of bridging the transmucosal form to the extended-release subcutaneous injectable form.
Journal: Journal of addictive diseases
Published: January 25, 2024
The Role of Non-Pharmaceutical Fentanyl-Contaminated Counterfeit Oxycodone in Increasing Opioid Overdoses: A Commentary Review.
Journal: The primary care companion for CNS disorders
Published: November 17, 2023
The Appearance of Xylazine in the United States as a Fentanyl Adulterant.
Journal: The primary care companion for CNS disorders
Published: November 03, 2023
The Effectiveness of Buprenorphine Transdermal Patch and Low Dose Sublingual Buprenorphine Induction to Transition to Long-Acting Subcutaneous Buprenorphine Injection in Opioid Use Disorder in Inpatient Setting.
Journal: Kansas journal of medicine
Published: August 13, 2023
Xylazine Use in Pregnancy: The Effects of the Fentanyl Adulterant Xylazine on Pregnant Patients and the Developing Fetus.
Journal: Kansas journal of medicine
Published: June 02, 2023
The Growing Epidemic of Opioid Use Disorder in the Elderly and Its Treatment: A Review of the Literature.
Journal: The primary care companion for CNS disorders
Published: January 13, 2023
Outpatient Rapid Microinduction of Sublingual Buprenorphine in 3 Days From Methadone for Opioid Use Disorder.
Journal: The primary care companion for CNS disorders
Published: December 30, 2022
Last Updated: 09/26/2026